Key Financial Data Of Group

ONO PHARMACEUTICAL CO., LTD. - Filing #7302958

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Revenue
240,339,000,000 JPY
502,672,000,000 JPY
258,713,000,000 JPY
Profit (loss) before tax
54,637,000,000 JPY
163,734,000,000 JPY
99,296,000,000 JPY
Profit (loss), attributable to owners of parent
41,641,000,000 JPY
127,977,000,000 JPY
74,491,000,000 JPY
Comprehensive income
8,196,000,000 JPY
137,890,000,000 JPY
80,632,000,000 JPY
Equity attributable to owners of parent
782,463,000,000 JPY
792,961,000,000 JPY
777,290,000,000 JPY
Total assets
1,046,406,000,000 JPY
913,668,000,000 JPY
895,918,000,000 JPY
Basic earnings (loss) per share
88.66
266.61
153.33
Diluted earnings (loss) per share
88.61
266.57
153.32
Ratio of owners' equity to gross assets
0.748 xbrli:pure
0.868 xbrli:pure
0.868 xbrli:pure
Cash flows from (used in) operating activities
34,723,000,000 JPY
110,660,000,000 JPY
36,721,000,000 JPY
Cash flows from (used in) investing activities
-160,930,000,000 JPY
48,077,000,000 JPY
20,713,000,000 JPY
Cash flows from (used in) financing activities
129,687,000,000 JPY
-89,848,000,000 JPY
-46,647,000,000 JPY
Cash and cash equivalents
167,090,000,000 JPY
166,141,000,000 JPY
107,704,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.